{"data":{"ticker":"GMED","slug":"globus-medical","name":"Globus Medical","exchange":"NYSE","sector":"Healthcare","headquarters":"Audubon, Pennsylvania","ceo":"Keith W. Pfeil","employees":6000,"website":"https://www.globusmedical.com","founded":"2003","layers":[{"slug":"ai-healthcare","name":"AI Healthcare"},{"slug":"robotics","name":"Robotics & Automation"}],"exposure":{"score":20,"tier":"Peripheral","rationale":"Globus Medical sells spine implants and the ExcelsiusGPS robotic navigation system to hospitals for AI-assisted surgery. Robotics adoption drives implant pull-through and is a genuine growth lever, but most revenue remains conventional musculoskeletal hardware."},"quote":{"price":71.05,"change24hPct":-12.76,"change7dPct":-8.97,"change30dPct":-3.11,"change1yPct":-15.31,"high52w":96.82,"low52w":71.05,"marketCap":9539309568,"peRatio":17.5,"eps":4.06,"volume24h":658788033},"nextEarningsDate":"2026-11-05","summary":"Globus Medical is a musculoskeletal device company. It makes money selling spine implants, orthopedic hardware, and surgical technology to hospitals and surgery centers, with robotic systems used to guide procedures and pull through implant sales.","explainer":["Globus Medical is a musculoskeletal device company. It makes money selling spine implants, orthopedic hardware, and surgical technology to hospitals and surgery centers, with robotic systems used to guide procedures and pull through implant sales.","Its AI-related line centers on the ExcelsiusGPS robotic navigation system, which supports AI-assisted spine surgery. Around it sit AI surgical planning tools, imaging-based AI navigation, and robotic spine software that help surgeons place implants with more precision.","Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical trades on the NYSE and employs about 6,000 people."],"buildoutRole":"Globus Medical sits in the AI Healthcare and Robotics & Automation layers of the AI buildout. Its ExcelsiusGPS robot brings AI-assisted navigation into spine and orthopedic operating rooms, and robot adoption helps sell more implants alongside it. That makes robotics a genuine growth lever for the company. Most revenue, though, still comes from conventional musculoskeletal hardware, so its AI exposure is a meaningful slice of the business rather than the core of it.","faq":[{"q":"What does Globus Medical do?","a":"Globus Medical sells spine implants, orthopedic hardware, and surgical technology to hospitals. Its ExcelsiusGPS robotic navigation system supports AI-assisted spine and orthopedic surgery and helps drive sales of the implants used in those procedures."},{"q":"How is Globus Medical exposed to AI?","a":"Mainly through surgical robotics. The ExcelsiusGPS robot, AI surgical planning, and imaging AI navigation are growth drivers, but most revenue is conventional implant hardware. Supercycle rates it an AI Exposure Score of 20 out of 100."},{"q":"What are Globus Medical's main products?","a":"Spine implants and orthopedic hardware, plus the ExcelsiusGPS robotic navigation system. Supporting technology includes AI surgical planning, imaging AI navigation, and robotic spine software used in AI-assisted procedures."},{"q":"What sector and categories is GMED in?","a":"Globus Medical is in the Healthcare sector. On Supercycle it is categorized under AI Healthcare and Robotics & Automation, reflecting its robotic surgical systems for spine and orthopedic procedures."},{"q":"Where is Globus Medical based and who leads it?","a":"Globus Medical is headquartered in Audubon, Pennsylvania, and is led by CEO Keith W. Pfeil. The company was founded in 2003 and employs about 6,000 people."}],"history1y":[{"date":"2026-09-28","close":74.78},{"date":"2026-09-29","close":75.69},{"date":"2026-09-30","close":74.9},{"date":"2026-10-01","close":74.41},{"date":"2026-10-02","close":75.6},{"date":"2026-10-05","close":76.57},{"date":"2026-10-06","close":76.43},{"date":"2026-10-07","close":73.75},{"date":"2026-10-08","close":73.33},{"date":"2026-10-09","close":74.65},{"date":"2026-10-12","close":76.24},{"date":"2026-10-13","close":76.32},{"date":"2026-10-14","close":76.31},{"date":"2026-10-15","close":78.84},{"date":"2026-10-16","close":76.71},{"date":"2026-10-19","close":75.65},{"date":"2026-10-20","close":78.96},{"date":"2026-10-21","close":78.68},{"date":"2026-10-22","close":81.66},{"date":"2026-10-23","close":81.41},{"date":"2026-10-26","close":81.83},{"date":"2026-10-27","close":80.9},{"date":"2026-10-28","close":81.26},{"date":"2026-10-29","close":82.91},{"date":"2026-10-30","close":78.05},{"date":"2026-11-02","close":79.46},{"date":"2026-11-03","close":79.58},{"date":"2026-11-04","close":87.1},{"date":"2026-11-05","close":81.44},{"date":"2026-11-06","close":71.05}],"incomeStatements":[{"ticker":"GMED","report_period":"2025-12-31","fiscal_period":"2025-FY","period":"annual","currency":"USD","revenue":2938931000,"cost_of_revenue":957802000,"gross_profit":1981129000,"operating_expense":0,"operating_income":537191000,"net_income":537868000,"earnings_per_share":3.92,"earnings_per_share_diluted":3.92,"research_and_development":147246000,"selling_general_and_administrative_expenses":1178498000,"interest_expense":0,"income_tax_expense":0,"weighted_average_shares_diluted":0},{"ticker":"GMED","report_period":"2024-12-31","fiscal_period":"2024-FY","period":"annual","currency":"USD","revenue":2519355000,"cost_of_revenue":1035479000,"gross_profit":1483876000,"operating_expense":0,"operating_income":219387000,"net_income":102984000,"earnings_per_share":0.75,"earnings_per_share_diluted":0.75,"research_and_development":163754000,"selling_general_and_administrative_expenses":981362000,"interest_expense":0,"income_tax_expense":0,"weighted_average_shares_diluted":0},{"ticker":"GMED","report_period":"2023-12-31","fiscal_period":"2023-FY","period":"annual","currency":"USD","revenue":1568476000,"cost_of_revenue":548174000,"gross_profit":1020302000,"operating_expense":0,"operating_income":201416000,"net_income":122873000,"earnings_per_share":1.07,"earnings_per_share_diluted":1.07,"research_and_development":124010000,"selling_general_and_administrative_expenses":643844000,"interest_expense":0,"income_tax_expense":0,"weighted_average_shares_diluted":0},{"ticker":"GMED","report_period":"2022-12-31","fiscal_period":"2022-FY","period":"annual","currency":"USD","revenue":1022843000,"cost_of_revenue":263725000,"gross_profit":759118000,"operating_expense":0,"operating_income":236251000,"net_income":190169000,"earnings_per_share":1.85,"earnings_per_share_diluted":1.85,"research_and_development":73015000,"selling_general_and_administrative_expenses":432117000,"interest_expense":0,"income_tax_expense":0,"weighted_average_shares_diluted":0}],"balanceSheets":[{"ticker":"GMED","report_period":"2025-12-31","fiscal_period":"2025-FY","period":"annual","currency":"USD","total_assets":5302761000,"current_assets":2125611000,"cash_and_equivalents":526156000,"total_liabilities":729511000,"current_liabilities":498499000,"total_debt":118656000,"shareholders_equity":4573250000,"retained_earnings":1387957000},{"ticker":"GMED","report_period":"2024-12-31","fiscal_period":"2024-FY","period":"annual","currency":"USD","total_assets":5251750000,"current_assets":2177260000,"cash_and_equivalents":784438000,"total_liabilities":1074417000,"current_liabilities":855913000,"total_debt":537188000,"shareholders_equity":4177333000,"retained_earnings":1152813000},{"ticker":"GMED","report_period":"2023-12-31","fiscal_period":"2023-FY","period":"annual","currency":"USD","total_assets":5086083000,"current_assets":1915374000,"cash_and_equivalents":467292000,"total_liabilities":1088124000,"current_liabilities":392347000,"total_debt":520404000,"shareholders_equity":3997959000,"retained_earnings":1137266000},{"ticker":"GMED","report_period":"2022-12-31","fiscal_period":"2022-FY","period":"annual","currency":"USD","total_assets":2076126000,"current_assets":983344000,"cash_and_equivalents":150466000,"total_liabilities":229753000,"current_liabilities":159204000,"total_debt":6011000,"shareholders_equity":1846373000,"retained_earnings":1239951000}],"holders13f":[],"news":[{"title":"GMED Q3 Earnings Call Highlights Guidance Cut and 2027 Reset","source":null,"url":"https://finance.yahoo.com/healthcare/articles/gmed-q3-earnings-call-highlights-140000587.html?.tsrc=rss","date":"2026-11-06"},{"title":"Globus Medical (GMED) Q3 2026 Earnings Call Transcript","source":null,"url":"https://www.fool.com/earnings/call-transcripts/2026/11/06/globus-medical-gmed-q3-2026-earnings-call-transcript/?.tsrc=rss","date":"2026-11-06"},{"title":"Compared to Estimates, Globus Medical (GMED) Q3 Earnings: A Look at Key Metrics","source":null,"url":"https://finance.yahoo.com/markets/stocks/articles/compared-estimates-globus-medical-gmed-233002893.html?.tsrc=rss","date":"2026-11-05"},{"title":"Globus Medical (GMED) Q3 Earnings Top Estimates","source":null,"url":"https://finance.yahoo.com/markets/stocks/articles/globus-medical-gmed-q3-earnings-214509361.html?.tsrc=rss","date":"2026-11-05"},{"title":"Globus Medical: Q3 Earnings Snapshot","source":null,"url":"https://finance.yahoo.com/healthcare/articles/globus-medical-q3-earnings-snapshot-213525934.html?.tsrc=rss","date":"2026-11-05"},{"title":"Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program","source":null,"url":"https://finance.yahoo.com/healthcare/articles/globus-medical-reports-third-quarter-210200025.html?.tsrc=rss","date":"2026-11-05"},{"title":"HIMS' Q3 Earnings: Can Weight Loss Momentum Drive Performance?","source":null,"url":"https://finance.yahoo.com/healthcare/articles/hims-q3-earnings-weight-loss-151400002.html?.tsrc=rss","date":"2026-11-06"},{"title":"Reasons to Add HealthEquity Stock to Your Portfolio for Now","source":null,"url":"https://finance.yahoo.com/markets/stocks/articles/reasons-add-healthequity-stock-portfolio-150500372.html?.tsrc=rss","date":"2026-11-06"}]},"meta":{"version":"v1","asOf":"2026-11-06","builtAt":"2026-11-08T15:24:45.630Z","tier":"free","source":"https://supercyclehq.com/stock/globus-medical","disclaimer":"Informational only, not investment advice. The AI Exposure Score is Supercycle's editorial opinion. Agent portfolios are simulated paper portfolios run by AI.","license":"Free to use and quote with attribution to supercyclehq.com. Do not redistribute as a dataset."},"links":{"self":"https://supercyclehq.com/api/v1/stocks/GMED","html":"https://supercyclehq.com/stock/globus-medical","md":"https://supercyclehq.com/stock/globus-medical.md","docs":"https://supercyclehq.com/api/v1/openapi.json"}}